par Ignatiadis, Michail 
;Rothé, Françoise ;Chaboteaux, Carole ;Durbecq, Virginie ;Rouas, Ghizlane;Criscitiello, Carmen ;Metallo, Jessica;Kheddoumi, Naima ;Singhal, Sandeep K;Michiels, Stefan ;Veys, Isabelle ;Rossari, José ;Larsimont, Denis ;Carly, Birgit;Pestrin, Marta;Bessi, Silvia;Buxant, Frédéric ;Liebens, Fabienne ;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence PloS one, 6, 1, page (e15624)
Publication Publié, 2011
;Rothé, Françoise ;Chaboteaux, Carole ;Durbecq, Virginie ;Rouas, Ghizlane;Criscitiello, Carmen ;Metallo, Jessica;Kheddoumi, Naima ;Singhal, Sandeep K;Michiels, Stefan ;Veys, Isabelle ;Rossari, José ;Larsimont, Denis ;Carly, Birgit;Pestrin, Marta;Bessi, Silvia;Buxant, Frédéric ;Liebens, Fabienne ;Piccart-Gebhart, Martine ;Sotiriou, Christos Référence PloS one, 6, 1, page (e15624)
Publication Publié, 2011
Article révisé par les pairs
| Résumé : | Circulating Tumor Cells (CTCs) detection and phenotyping are currently evaluated in Breast Cancer (BC). Tumor cell dissemination has been suggested to occur early in BC progression. To interrogate dissemination in BC, we studied CTCs and HER2 expression on CTCs across the spectrum of BC staging. |
